Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Erbitux

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Erbitux was produced by Merck & Co. and Bristol-Myers Squibb.

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

it introduced colorectal and head and neck cancer therapy Erbitux (cetuximab) more than a decade ago.

NICE expands Merck KGaA’s Erbitux reach

NICE expands Merck KGaA’s Erbitux reach NICE expands Merck KGaA’ s Erbitux reach. Backs the medicines use for patients with SCCHN. ... access to Erbitux and that NICE has recognised the survival benefit it can offer to patients with this disease.”.

Can NICE deliver on its funding promises?

Can NICE deliver on its funding promises? Moreover, while no product has yet received a negative final decision, draft ‘no’s for Kadcyla, Adcetris and Erbitux will have put Roche, Takeda and Merck KGaA on notice.

Trials of AZ's durvalumab restart as FDA hold is relaxed

Trials of AZ's durvalumab restart as FDA hold is relaxed KESTREL is comparing durvalumab and tremelimumab in combination or durvalumab monotherapy to Eli Lilly's Erbitux (cetuximab) plus chemotherapy, while EAGLE is comparing the same two AZ regimens with the standard

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics